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Background: The aetiology of cerebral small vessel disease is unknown. An 
association with endothelial dysfunction has been suggested. We systematically 
assessed all relevant studies of dynamic endothelial function in patients with lacunar 
stroke, as a marker of small vessel disease. 
Methods: We searched for studies of cerebral or peripheral vascular reactivity in 
patients with lacunar or cortical (i.e. large artery atheromatous) ischaemic stroke or 
non-stroke controls. We calculated standardised mean difference (SMD) in vascular 
reactivity, +/- 95% confidence intervals (CI) between small vessel disease and 
control groups. 
Results: Sixteen publications (974 patients) were included. In lacunar stroke: 
cerebrovascular reactivity (n=534) was reduced compared with age-matched normal 
(SMD -0.94, 95%CI -1.17, -0.70), but not age+risk factor-matched controls (SMD 
0.08, 95%CI -0.36, 0.53) or cortical strokes (SMD -0.29, 95%CI -0.69, 0.11); forearm 
flow mediated dilatation (n=401) was reduced compared with age-matched normal 
controls (SMD -1.04, 95%CI -1.33, -0.75) and age+risk factor-matched controls 
(SMD -0.94, 95%CI -1.26, -0.61), but not cortical strokes (SMD -0.23, 95%CI -0.55, 
0.08).  
Conclusions: Endothelial dysfunction is present in patients with lacunar stroke but 
may simply reflect exposure to vascular risk factors and having a stroke, as a similar 
degree of dysfunction is found in cortical (large artery atheromatous) stroke. Current 
data do not confirm that endothelial dysfunction is specific to small vessel stroke. 
Future studies should include controls with non-lacunar stroke. 
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Introduction 
Cerebral small vessel disease (SVD) is common and has clinical (lacunar stroke, 
cognitive impairment, gait and movement disorders) and radiological (symptomatic 
small subcortical infarct, silent lacunar infarct, lacunes, white matter lesions (WMLs), 
microbleeds) manifestations.1-3 The low early mortality of lacunar stroke masks a 
long-term risk of recurrent stroke and death similar to atherothromboembolic stroke,4 
and substantial risk of cognitive decline,5 creating a massive public health burden.6 
 
Lacunar infarcts are small (<15mm) subcortical lesions in the territory of a single 
deep perforating arteriole most of which are associated with an intrinsic abnormality 
in the perforating arteriole wall of unknown aetiology. An association between 
lacunar ischaemic stroke and endothelial dysfunction has been suggested,7;8 but 
many patients with stroke have hypertension or diabetes or take medications which 
affect endothelial function.9;10 Atheromatous large artery disease is also associated 
with endothelial dysfunction.11 A recent systematic review identified endothelial 
dysfunction in lacunar ischaemic stroke but did not control for risk factor exposure or 
other stroke subtypes.12 Therefore it is unclear whether endothelial changes 
observed in patients with lacunar ischaemic stroke might be specific to SVD or 
simply reflect age, vascular risk factors, generalised (possibly co-incidental) 
atheroma or the effects of having a stroke. We performed a systematic review of all 
studies that assessed cerebral or peripheral vascular reactivity in patients with 
lacunar ischaemic stroke. 
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Methods 
We followed the general guidance for systematic reviews of observational and 
diagnostic studies (http://www.equator-network.org), modified to suit the type of 
study identified in this review.13;14 
 
We searched the published literature using MEDLINE and EMBASE from the 1st 
January 1995, to the 15th February 2008 using Ovid and a carefully devised search 
strategy (Appendix 1) developed with advice from the Cochrane Stroke Group 
(http://www.dcn.ed.ac.uk/csrg/). We updated the search using MEDLINE to 6th 
January 2010 (we did not re-search EMBASE as there was very little difference 
between it and MEDLINE in the initial search). We sought primary studies, in 
humans, in any language, which investigated patients with markers of cerebral SVD 
and dynamic measures of endothelial function e.g. response to hypercapnia or 
acetazolamide or flow mediated dilatation.15 We checked references in review and 
primary papers and hand-searched the journal Stroke. 
 
We included papers which assessed endothelial function in patients with: clinically-
evident lacunar ischaemic stroke, with or without an acute subcortical infarct on brain 
imaging; lacunes (i.e. rounded cerebral spinal fluid attenuation lesion <1.5mm in the 
basal ganglia, hemispheric white matter or brain stem) identified on brain imaging 
without clearly-relevant symptoms; or leukoaraiosis (WMLs).  
 
We excluded papers which only assessed endothelial function using plasma 
markers, animal studies, duplicate publications, SVD caused by a single gene 
disorder or had no control group.  
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Two reviewers independently extracted data using a standardised data extraction 
form. A third reviewer arbitrated on disagreements. We obtained translations of 
foreign language papers where possible. We extracted data on study population 
(sample size, age, sex, presence of co-morbidities, medications, previous strokes 
and selection criteria for both patient and control groups), study design, endothelial 
function assessment method,15 vascular bed, blinding of investigators and primary 
vascular reactivity results. We identified the method of stroke diagnosis, whether by 
a stroke specialist, if confirmed using imaging, the type of imaging and the time 
interval after stroke. We assessed the study quality using the QUADAS14 instrument 
(www.equator-network.org). We were careful to include each patient population only 
once while including all data available for that population. 
 
The studies used different methods of assessing endothelial function, so we 
calculated the standardised mean difference (SMD) by the fixed effects method 
(Review Manager 4© software) between the lacunar and control groups from the 
mean and standard deviation of the vascular reactivity results (where given). We 
used the endothelial function data from the cerebral circulation contralateral to the 
side of the symptomatic infarct in cortical and lacunar stroke patients. As most 
studies did not adjust for potential confounders, we stratified the analyses into 
lacunar vs. age-matched controls; vs. age+risk factor-matched controls; vs. cortical 
stroke; and multiple vs. single lacunar infarcts on imaging. We calculated 
heterogeneity between studies. 
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Results 
We identified 1257 titles. De-duplication (467) and exclusion of irrelevant papers 
(n=739) resulted in 27 includable papers. Hand searching identified three additional 
publications. Of the 30 for full text reading, three were excluded (unable to translate: 
Russian16 and Slovakian17;18) and eleven failed to meet the inclusion criteria (no 
controls,19;20 not assessing dynamic endothelial function or inappropriate patients21-
29). Therefore 16 papers were eligible, including 974 individuals. 
 
Characteristics of included studies (Table 1) 
Some of the 16 papers contributed to more than one comparison: 14/16 papers30-43 
compared 318 patients with recent lacunar ischaemic stroke to 305 age-matched or 
age+risk factor matched controls; 5/15 papers35;37;38;42;44 compared 124 patients with 
recent lacunar ischaemic stroke to 115 patients with recent cortical ischaemic stroke; 
4/15 papers30;37;40;45 compared patients with recent lacunar ischaemic stroke of 
whom 71 had only one single small subcortical infarct and 71 had a single 
symptomatic lacunar infarct plus multiple silent infarctions on imaging.  
 
Most studies were small (mean 36 subjects, median 18 subjects per group), gave 
little detail about recruitment or methods of stroke diagnosis (in particular of how 
lacunar stroke was determined), did not state duration of hypertension or other risk 
factors, adjust for risk factors37 or mention prescribed medications (only two stated 
that medications were discontinued prior to study35;40). Only two studies explicitly 
stated that the analyses were blinded to subject group. Ten gave the time interval 
between stroke and endothelial function assessment (range <72 hours to three 
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months, median 26 days). The lacunar and cortical ischaemic stroke patients were 
not age-matched.  
 
Characteristics of included patients and controls 
All 16 papers defined lacunar ischaemic stroke as “appropriate neurological features 
and a recent small subcortical infarct on imaging consistent with the symptoms”. 
Most papers excluded patients with carotid stenosis (except one30), five excluded 
cardiogenic sources of emboli,32;33;36;38;41 and three excluded middle cerebral artery 
(MCA) stenosis35;39;40 from the lacunar stroke group. 
 
Thirteen studies had age-matched medically-confirmed normal controls; 5/13 also 
used imaging to exclude subjects with silent infarcts.30;32;39;40;42 Three studies 
recruited age- and risk-factor matched controls (with long-standing hypertension and 
hypercholesterolaemia in two;32;34 with hypertension only in one43). Five papers 
compared patients with lacunar ischaemic stroke to patients with cortical ischaemic 
stroke,35;37;38;42;44 confirming the infarct subtype with CT or MRI. Four studies 
included patients with more than one lacunar infarct on CT,30;37;40;45 MR,40;45 or 
both.37 
 
Assessment of endothelial function (Table 1) 
Twelve papers assessed endothelial function in the cerebral circulation30-32;34;37-
42;44;45 and five papers the systemic circulation;32;33;35;36;43 one assessed both.32 
Several techniques (Table 1) were used to assess cerebral endothelial function, 
including the vascular response to hypercapnia, infusion of acetazolamide or L-
arginine, expressing the response as a percentage increase in mean arterial blood 
  9
velocity in the MCA or basilar artery. Change in blood oxygen level dependent signal 
during hypercapnia detected using functional MRI,31 percent increase in regional 
cerebral blood flow in response to hypercapnia using stable Xenon CT30 and 
“dynamic cerebral autoregulation” (the ability to restore cerebral blood flow following 
sudden changes in perfusion pressure)38 were also used. Peripheral endothelial 
function was assessed with brachial artery flow-mediated dilatation, expressed as 
the percentage change in arterial diameter, in five papers;32;33;35;36;43 one also 
assessed endothelium-independent flow-mediated dilatation using response to 
sublingual nitroglycerine.43 
 
Endothelial function: Lacunar stroke vs. age-matched controls  
Thirteen studies (n=534) compared lacunar ischaemic stroke to healthy age-matched 
controls, nine in the cerebral (n=360)30-32;34;37;39-42 and four in the peripheral 
circulation (n=211).32;33;35;36 Vascular reactivity was reduced in the cerebral 
circulation in lacunar stroke patients compared with age-matched healthy controls 
(8/9 studies, 324 patients, SMD -0.94, 95% confidence intervals (CI) -1.17, -0.70, 
p<0.00001, Figure 1) and in the forearm (4/4 studies, 211 patients, SMD -1.04, 95% 
CI -1.33, -0.75, p<0.00001, Figure 2). There was no significant heterogeneity 
between studies. 
 
Lacunar ischaemic stroke vs. age+risk factor-matched controls  
Four papers compared vascular reactivity in lacunar stroke patients with age+risk-
factor-matched controls, two in the cerebral32;34 and three in the peripheral 
circulation.32;33;43 There was no significant difference in cerebrovascular reactivity 
(2/2 studies, 79 patients, SMD 0.08, 95% CI -0.36, 0.53, p=0.71, Figure 1) but 
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significantly impaired peripheral vascular reactivity (3/3 studies, 167 patients, SMD -
0.94, 95% CI -1.26, -0.61, p<0.00001, Figure 2). There was no significant 
heterogeneity between studies.  
 
Lacunar vs. cortical ischaemic stroke  
Four of the 16 studies (n=127)37;38;42;44 compared cerebral vascular reactivity in 
patients with lacunar stroke (n=68) to patients with cortical stroke (n=54), of which 
two studies contributed to more than one comparison (Figure 1). One study (n=117) 
compared peripheral vascular reactivity between lacunar (n=56) and cortical (n=61) 
stroke patients (Figure 2).35 For the cerebral comparisons, we used the test results 
from the asymptomatic side of the brain, because vascular reactivity was reduced in 
ipsilateral vs. contralateral arteries in cortical stroke patients due to tissue damage 
resulting from the stroke (see Table 1). Although individual studies showed 
differences in endothelial function between lacunar and cortical stroke 
patients35;37;38;42;44 the combined data showed no difference in vascular reactivity 
between lacunar and cortical stroke in either cerebral (SMD -0.29, 95% CI -0.69, 
0.11, p=0.16) or in peripheral (SMD -0.23, 95% CI -0.55, 0.08, p=0.15) circulation. 
There was no significant heterogeneity between studies.  
 
Lacunar ischaemic stroke with single  vs. multiple silent lacunar infarcts  
Four of the 16 papers30;37;40;45 compared cerebral vascular reactivity in lacunar stroke 
patients with one single lacunar infarction (n=71) to those with additional multiple 
silent infarctions (n=71) on imaging (Figure 1). Patients with lacunar ischaemic 
stroke plus multiple silent lacunar infarcts had reduced cerebral vascular reactivity 
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compared to patients without silent lacunar infarcts on imaging (SMD -0.68, 95% CI -
1.02, -0.34, p=0.0001), with no significant heterogeneity between studies.  
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Discussion 
Endothelial dysfunction is common in patients with symptomatic large artery 
atheromatous disease and has also been postulated as a mechanism underlying the 
development of lacunar stroke. This systematic review suggests that lacunar 
ischaemic stroke is associated with impaired vascular reactivity compared with 
normal age-matched controls, but the association is less clear-cut when compared 
with controls matched for vascular risk factors or patients with cortical ischaemic 
stroke. One interpretation of this is that endothelial dysfunction may be a general 
response of the vascular system to the vascular risk factors that predispose to 
stroke,9 or other circumstances associated with stroke such as secondary prevention 
medications, rather than being specific to small or large artery disease. 
 
A previous systematic review identified associations between lacunar stroke and 
altered vascular reactivity, but did not perform a meta-analysis or make direct 
comparisons between lacunar stroke and patients with vascular risk factors or 
cortical stroke controls.12 Endothelial function is altered in the presence of vascular 
risk factors9 and by drugs used for risk factor reduction and stroke prevention.10 
Cortical stroke patients control for use of medications and presence of vascular risk 
factors so are the most valid comparison.46 It is worth noting that the presence of an 
infarct in the brain was associated with reduced ipsilateral vascular reactivity, e.g. 
cortical stroke patients had reduced reactivity ipsilateral to the ischaemic cortical 
stroke. Hence any reduction in cerebral vascular reactivity in patients with multiple 
silent lacunar infarcts on imaging in both hemispheres (compared to patients with 
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only a single lacunar infarct) is unsurprising and is likely to be a consequence of 
more brain damage.  
 
The strengths include following well-established guidance for conducting systematic 
reviews of observational and diagnostic data (www.equator-network.org) and 
Cochrane Stroke Group search advice. We used standard pre-specified criteria for 
study assessment. We carefully avoided duplicate data. Some studies provided 
more than one comparison but we were careful to avoid double counting the total 
number of subjects. In patients with stroke, we only used the cerebral vascular 
reactivity results from the asymptomatic side of the brain to avoid simply measuring 
the effects of brain damage resulting from the index stroke. We meta-analysed the 
data thereby effectively increasing sample size and precision. 
 
The limitations include the small number of relevant studies, their small sample size, 
the varied and often poorly described diagnosis of lacunar stroke and the various 
and poorly standardised endothelial function tests used. In general, the papers gave 
little detail about how the diagnosis of lacunar stroke had been made clinically and/or 
with imaging, so inevitably there will be some “noise” due to imprecise diagnoses. 
However, given the relative lack of literature on this topic, we decided that it would 
be better to include studies which appeared to have included patients with 
symptomatic lacunar stroke as any attempt to exclude studies on the basis of their 
lacunar stroke diagnosis could have resulted in further bias. Studies which used 
suboptimal imaging, either insensitive or applied too late after the acute symptoms, 
may have confused up to 20% of lacunar strokes as cortical strokes and vice 
versa.47 It was often unclear if the investigators were blind to study group; unblinding 
  14
may increase investigator bias. The endothelial function data were not adjusted for 
potential confounders such as blood pressure, diabetes, hypercholesterolaemia, 
smoking, prior stroke, white matter hyperintensities on imaging, old infarcts or 
haemorrhages on imaging, age or medication. Although studies generally matched 
with healthy controls for age, the lacunar and cortical stroke groups were not well 
age-matched. Despite many antihypertensive and stroke prevention medications 
being known to influence endothelial function, there was little information about 
current medications, most studies did not indicate if medications had been stopped 
prior to the study, and where this was mentioned, it was a very short time (e.g. 12 
hours35) before the endothelial function studies. While some studies used hospital 
controls, recruitment procedures (source, mechanism) were unclear for many 
studies. Other limitations reflect the limited resources available for this review, e.g. 
we were unable to obtain translations for three papers which might have contained 
relevant data. The cerebral circulation studies used several different endothelial 
function tests.15 However it is important to realise that the meta-analysis does not 
directly compare studies with each other, but rather the magnitude of association 
within each study with that in other studies. Therefore the grouping of apparently 
different methods of assessing endothelial function is more valid than attempting to 
combine data from different studies that used different methods in an individual 
patient data meta-analysis. There is also likely to be publication bias, meaning that 
the present analyses are over positive. 
 
Is there a need for further research on endothelial function and lacunar stroke? The 
existing data do not exclude a specific association between endothelial dysfunction 
and lacunar stroke. Based on the modest difference in the cerebral circulation 
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between lacunar and cortical patients identified in this review and the large standard 
deviation (SD) of the endothelial function measurement methods, a future study 
would require a total sample size of 570 patients (half lacunar and half cortical) to 
confirm a difference in cerebral vascular reactivity of 22%, SD 20%, with 80% power 
at the p<0.05 level, particularly if there were to be any adjustment for even a few key 
potential confounding variables. If the SD could be reduced, e.g. by increasing the 
precision of the endothelial function measurements (although ±20% is biologically 
very plausible and any less would be unlikely), then the sample sizes would be 
smaller. On the other hand, a difference of 22% is optimistic, the differences in the 
present studies being nearer 6%, in which case a sample size of 752 would be 
required. The studies to date were much smaller than this. Numerous studies report 
plasma markers of endothelial function (e.g. asymmetric dimethylarginine12;48) and 
lacunar disease, but the identification and meta-analyses of these studies was 
beyond the remit of this review. There may be an association between angiotensin-
converting enzyme insertion/deletion polymorphism (influencing endothelial function) 
and leukoaraiosis,49 but the results of genetic association studies are awaited.  
 
In addition to including a control group with a pathophysiologically different subtype 
of ischaemic stroke, future studies should ensure optimal clinical and imaging 
diagnosis of stroke subtype, provide clear descriptions of their recruitment and 
assessment methods, ensure adequate blinding of endothelial assessments, have 
appropriate controls drawn from a relevant and comparative population, record 
medications, try to balance study groups for medications, preferably discontinue 
vasoactive drugs prior to study, adjust for differences in vascular risk factors, and 
match for age. The peripheral circulation provides a valuable method of examining 
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systemic endothelial dysfunction outside the territory affected by the recent stroke. 
Cerebral small vessel disease may be a systemic small vessel problem affecting 
multiple organs,8;50 in the same way that large artery atheroma is rarely a disease of 
only one large artery, and therefore it is legitimate and necessary to study small 
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Table 1. Dynamic endothelial function in the a) cerebral and b) peripheral circulation. Included studies evaluating dynamic cerebral and peripheral endothelial 
function in patients with lacunar stroke and controls. 
a) Cerebral circulation 
Endothelial function 











method Lacunar Controls 











18 (61.1±7.6) 19 (59.2±7.1) TOAST CT % increase in mean 
MCA blood flow 





2006 Lacunar stroke 20 (60.9±6.2) 21 (59.5±7.3) Not stated CT % increase in mean 
MCA blood flow 
velocity on TCD after 
L-arginine 
13.4±9.1 20.5±9.9 
stable xenon CT:  7.3± 6.0 14.3±11.5 Mochizuki30 1997 Single lacunar 
stroke 
15 (63.5) 16 (58.4) Not stated CT 
absolute % increase 
in rCBF of white 
matter after 
acetazolamide 
41.9% 60.3% ↑ 




46 (58.3±12) Based on 
imaging 
MRI % increase in mean 




increase in mean BA 
flow velocity on TCD 
after acetazolamide 
(%) 




10 (64.4±4.3) Not stated CT/MRI 
Response to hyper-
capnia cm/sec/kPA 
3.4± 5.0 10.1± 4.9 




12 (52±12.1) Not stated CT/MRI % increase in mean 
MCA blood flow 
velocity on TCD per 















method Lacunar Controls 
CO2 
Maeda42 1993 Lacunar stroke 20 (59.6±6.8) 25 (57.3±6.5) NINDS CT Mean spatial Doppler 
frequency=A exp(k 
Pet CO2) hypercapnia 
0.028±0.004 0.033±0.005 
Cupini37) 2001 Lacunar stroke 14 (61.4±9.2) 15 
(57.66±12.7) 
Not stated CT/MRI BHI: ∆MFV/Baseline 
MFV x 100/s 






5 (61.8) 6 (57) Not stated MRI Measured using fMRI: 
BOLD signal volume 
decrease (cm3) 
change normalised to 
ET- CO2 
290±190 480±160 
Immink38 2005 Lacunar stroke 10 (63±3) 10 (57±2) Not stated CT/MRI delay (in seconds) of 
MCA Vmean counter-
regulation during 





i.e. no latency 
of response 
5.3±0.5  








2006 Lacunar stroke 
with hyperchol-
esterolaemia 
18 (61.1±7.6) 20 (62.7±5.3) TOAST CT % increase in mean 
blood velocity on TCD 
after L-arginine 





20 (60.9 ±7.3) 21 (61.0±6.2) Not stated CT % increase in mean 
blood velocity on TCD 
after L-arginine 
13.4 ±9.1 11.5 ±8.9 








23 (72±13.7) Not stated CT/MRI % increase in mean 
blood velocity after 




















method Lacunar Controls 
(contralateral) (contralateral) 
Maeda42 1993 Lacunar 
infarction 
20 (59.6±6.8) 8 (53.5±9.5) NINDS CT/MRI Mean spatial Doppler 
frequency=  
A exp(k Pet CO2) 









Cupini37 2001 Lacunar 
infarction 
14 (61.4±9.2) 13 
(53.9±11.8) 
Not stated CT/MRI BHI: ∆MFV/Baseline 









Immink38 2005 Lacunar 
infarction 
10 (63±3) 10 (59±5) Not stated CT/MRI dCA: delay of MCA 
Vmean counter-
regulation during 









Single vs. multiple lacunar infarcts on 
imaging Single  Multiple 
 




21 (NA) 22 (NA) Stroke Data 
Bank 
MRI % increase in mean 














26 (NA) 20 (NA) Based on 
imaging 
MRI % increase in mean 

















method Lacunar Controls 
stable xenon CT 
method increase in 
rCBF of white matter 
after acetazolamide 
(contralat only) 
absolute increase: 5.0±3.4 7.3±6.0 








Not stated CT 
% increase : 34.2% 41.9% 








Not stated CT/MRI BHI: ∆MFV/Baseline 











b) Peripheral circulation 
Endothelial function 












method Lacunar Controls 









18 (61.1±7.6) 19 (59.2±7.1) TOAST CT Flow mediated 
dilatation: % increase 
in brachial artery 





2006 Lacunar stroke 20 (60.9±7.3) 21 (59.5±7.3) Scan based CT Flow mediated 
dilatation: % increase 
in brachial artery 
diameter, after cuff 
inflation+deflation 
0.4±5.0 7.9 ± 6.0 % 
Chen35 2006 Lacunar stroke 56(67.7±10.2)§ 40 (66.7±8.3) TOAST CT/MRI Flow mediated 
dilatation: % increase 
in brachial artery 
diameter after cuff 
inflation+deflation 
4.3±6.1 8.8±6.0 
Lavallee36 2006 Lacunar stroke 17 (61±21) 20 (60±25) Not stated Not stated Flow mediated 
dilatation: % increase 
in brachial artery 
diameter after cuff 
inflation+deflation 
4.2±1.1 6.7±2.5 
Lavallee36 2006 Lacunar stroke 17 (61±21) 20 (60±25) Not stated Not stated Flow mediated 
dilatation: % increase 
in carotid artery 
diameter after CO2 
4.0±1. 11.4±2.7 























method Lacunar Controls 
Oblak (a)32 with 
hypercholesterol-
aemia 
dilatation: % increase 
in brachial artery 




2006 Lacunar stroke 20 (60.9±7.3) 20 (61.0±6.2) Scan based CT Flow mediated 
dilatation: % increase 
in brachial artery 
diameter after cuff 
inflation+deflation 
0.4±5.0 3.8±4.8 
Kim43 2009 Lacunar 
ischaemic stroke 




MR Flow mediated 
dilatation: % increase 
in brachial artery 












Chen35 2006 Lacunar stroke 
vs. large artery 
atheroma stroke 
56(67.6±10.2)§ 40 (67.8±8.2) TOAST CT/MRI Flow mediated 
dilatation: % increase 
in brachial artery 




“Chen 2” in 
Fig 2 
2006 Lacunar stroke 
vs. cardio embolic 
stroke 
56(67.6±10.2)§ 21 (67.6±9.2) TOAST CT/MRI Flow mediated 
dilatation: % increase 
in brachial artery 
diameter after cuff 
inflation+deflation 
4.3±6.1 5.6±5.0 
*for back to back BP changes; +for flow mediated dilatation in response to sublingual nitroglycerine (endothelium independent dilatation); § note that there are 
56 patients with lacunar stroke in total in Chen 2006, not 56 x 3. BA, basilar artery; BHI, breath holding index; BOLD, blood oxygen level dependent; CT, 
computerised tomography; fMRI, functional magnetic resonance imaging; MAP, mean arterial pressure; MCA, middle cerebral artery; MFV, mean flow 
velocity; MRI, magnetic resonance imaging; rCBF, regional cerebral blood flow; TCD, transcranial Doppler. 
Figure 1 Forest plot showing standardised mean difference (SMD) in 
cerebrovascular reactivity in patients with lacunar ischaemic stroke vs. age-matched, 
age+risk factor matched and cortical ischaemic stroke controls and in patients with 
lacunar ischaemic stroke with vs. without multiple silent lacunar infarcts. Squares 
represent the ratio of the lacunar response divided by the control response with the 
solid black lines representing the 95% CI. The diamond represents the summary 
result. 
 
Figure 2  Forest plot showing standardised mean difference (SMD) in peripheral 
endothelial function in patients with lacunar ischaemic stroke vs. age-matched, age 
and risk factor matched and cortical ischaemic stroke controls. See Figure 1 for 
legend. Note that Chen35 provided data for cortical stroke as carotid stenosis (a) and 
cardioembolic ( b) mechanisms separately, not for “all cortical stroke”, hence there 
are two entries for Chen (a and b) under “lacunar vs cortical” – thus the 56 patients 







Appendix 1: Search Strategy 
 1. brain ischemia/ or brain infarction/ or brain stem infarctions/ or cerebral infarction/ 
or hypoxia-ischemia, brain/ or stroke/ 
2. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or 
attack$)).tw. 
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or 
intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior 
circulation) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or 
hypoxi$)).tw. 
4. 1 or 2 or 3 
5. (lacun$ or small vessel$ or small infarct$ or microinfarct$ or subcortical lesion$ or 
subcortical infarct$ or microvascular$ or microcirculation$).tw. 
6. 4 and 5 
7. blood-brain barrier/ or endothel$, vascular/ or tunica intima/ or microcirculation/ 
8. (endotheli$ adj5 (function$ or dysfunction$ or impairment$)).tw. 
9. ((vascular or capillary) adj5 endotheli$).tw. 
10. (endotheli$ adj5 (contraction or relaxation)).tw. 
11. vascular tone/ or arterial stiffness.mp. [mp=title, original title, abstract, name of 
substance word, subject heading word] 
12. (vascul$ tone or neurovasc$ coupl$ or arterial stiff$ or vascul$ remodel$ or 
cerebrovascular reactiv$ or cerebral autoregulation).tw. 
13. (Flow mediated adj3 (dilat$ or vasodilat$)).tw. 
14. exp Ultrasonography, Doppler, Transcranial/ 
15. pulse wave analysis.tw. 
16. strain gauge plethysmography.tw. 
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17. (brachial artery or radial artery or popiteal artery or posterior tibial artery).tw. 
18. or/7-17 
19. 6 and 18 
20. limit 19 to yr="1995 - 2008" 
21. limit 19 to humans 
22. limit 21 to humans 
23. from 22 keep 1-376 
24. (strain gauge plethysmography or venous occlusion plethysmography).tw. 
25. forearm blood flow.tw. 
26. (dorsal hand vein technique or aellig technique).tw. 
27. stimulated tPA release.tw. 
28. or/24-27 
29. 18 or 28 
30. 6 and 29 
 
 
 
